estrogen receptor antagonist
An antagonist at the estrogen receptor.
|
|
estrogen receptor antagonist
An antagonist at the estrogen receptor.
anti-estrogen
A drug which acts to reduce estrogenic activity in the body, either by reducing the amount of estrogen or by reducing the activity of whatever estrogen is present.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
N-butyl-11-[3,17β-dihydroxyestra-1(10),2,4-trien-7α-yl]-N-methylundecanamide
|
ICI 164,384
|
ChemIDplus
|
ICI 164384
|
ChemIDplus
|
ICI M164384
|
ChemIDplus
|
ICI-164,384
|
ChEBI
|
ICI164384
|
ChEBI
|
N-butyl-11-[(7α,9β,13α,14β,17α)-3,17-dihydroxyestra-1,3,5(10)-trien-7-yl]-N-methylundecanamide
|
PDBeChem
|
N-butyl-11-[(7R,8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-7-yl]-N-methyl-undecanamide
|
PDBeChem
|
N-n-butyl-N-methyl-11-(3,17β-dihydroxyestra-1,3,5(10)-trien-7α-yl)undecanamide
|
ChEBI
|
N-n-butyl-N-methyl-11-[3,17β-dihydroxyestra-1,3,5(10)-trien-7α-yl]undecanamide
|
KEGG COMPOUND
|